The 20 Best Blood Clots Doctors Near Me in Columbia, MD

Andrew Mener, M.D. has experience treating a wide range of adult hematologic and oncologic disorders, with a particular interest in treating breast, lung, gastrointestinal and hematologic malignancies. He takes great pride in delivering personalized, compassionate care and strives to effectively explain complex treatment options to his patients. He strongly believes in the importance of treating each and every patient as an individual. Learn more at marylandoncology.com. Dr. Mener is rated as an Experienced provider by MediFind in the treatment of Blood Clots. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Severe Congenital Neutropenia. Dr. Mener is board certified in American Board Of Internal Medicine.

Edward Lee, M.D. was named one of Baltimore’s “Top Doc’s” by Baltimore Magazine in 2000 and 2002. After receiving additional training in Hematology and Medical Oncology at the University of Maryland in 1984, he remained on faculty until 1997. During his academic career, Dr. Lee was chairman of the training program for five years, started the Bone Marrow Transplant Program at the University of Maryland in 1993, and wrote 50 original articles on leukemia, lymphoma and related diseases. In 1997, Dr. Lee entered private practice as Chief of Hematology and Medical Oncology at Sinai Hospital. Practicing in Columbia since 2001, Dr. Lee treats patients with all forms of cancer, maintaining a particular interest in breast cancer, leukemia, and lymphomas. Learn more at marylandoncology.com. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Blood Clots. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Paget Disease of the Breast, Breast Cancer, and Primary Lymphoma of the Brain. Dr. Lee is board certified in American Board Of Internal Medicine.

As an active participant in the medical community, Mohit Narang, M.D. has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology. Learn more at marylandoncology.com. Dr. Narang is rated as an Experienced provider by MediFind in the treatment of Blood Clots. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Agranulocytosis, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Transplant. Dr. Narang is board certified in American Board Of Internal Medicine.

Learn more at marylandoncology.com. Dr. Sastry is rated as an Experienced provider by MediFind in the treatment of Blood Clots. She is also highly rated in 52 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia. Dr. Sastry is board certified in American Board Of Internal Medicine.

Dr. Shruti Chaturvedi is an Associate Professor of Medicine at Johns Hopkins. She received her medical degree from Maulana Azad Medical College, University of Delhi, India. She then completed a residency in Internal Medicine at the Cleveland Clinic, Cleveland, OH, and a fellowship in Hematology and Oncology at Vanderbilt University, Nashville, TN. She has additionally obtained a Master of Science in Clinical Investigation (MSCI) degree from Vanderbilt University. Dr. Chaturvedi specializes in the care of adults with non-malignant hematologic disorders including thrombocytopenic purpura, atypical hemolytic uremic syndrome, antiphospholpiid syndrome, immune thrombocytopenia, autoimmune hemolytic anemia, thrombotic, other bleeding and clotting disorders, and anemias. Her research is focused on improving the care of patients with thrombotic microangiopathies with a focus on long term sequelae, and the role of complement in thrombotic disorders such as the antiphospholipid syndrome. Dr. Chaturvedi is rated as a Distinguished provider by MediFind in the treatment of Blood Clots. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Atypical Hemolytic Uremic Syndrome (aHUS), Blood Clots, Anemia, Splenectomy, and Bone Marrow Aspiration.

Shoaib Hashmi is a primary care provider, practicing in Internal Medicine in Columbia, Maryland. Dr. Hashmi is rated as an Advanced provider by MediFind in the treatment of Blood Clots. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Anemia, Familial Hypertension, and Hypertension.

Andrew Lazris is a primary care provider, practicing in Internal Medicine in Columbia, Maryland. Dr. Lazris is rated as an Experienced provider by MediFind in the treatment of Blood Clots. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Urinary Tract Infection in Children, Familial Hypertension, Dementia, and Muscle Atrophy.

Mateen Awan is a primary care provider, practicing in Internal Medicine in Columbia, Maryland. Dr. Awan is rated as an Experienced provider by MediFind in the treatment of Blood Clots. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Nephrosclerosis, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Gastrostomy, and Endoscopy.

Martin Engelhardt is a Cardiologist practicing medicine in Ellicott City,, Maryland. Dr. Engelhardt is rated as an Experienced provider by MediFind in the treatment of Blood Clots. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Familial Dilated Cardiomyopathy, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Advanced provider by MediFind in the treatment of Blood Clots. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine.

Charles Cummings is a Cardiologist practicing medicine in Pikesville,, Maryland. Dr. Cummings is rated as an Advanced provider by MediFind in the treatment of Blood Clots. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Atherosclerosis, Coronary Heart Disease, Angina, Pacemaker Implantation, and Heart Bypass Surgery.

As a physician scientist in the hematological malignancies and stem cell transplantation division with Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins, my focus is on the various aspects of cellular therapy in the treatment of hematological malignancies. My primary research focus is to develop strategies to prevent relapse of hematological malignancies following allogeneic stem cell transplantation. Additionally, I serve as the director of the adult CAR T program for hematological malignancies as we grow our CAR T program to help patients with advanced hematological malignancies. My academic interest in this space lies in studying the aspects of toxicity of CAR T cell therapy with an aim to improve long term outcomes in these patients. Among hematological malignancies, myeloproliferative disorders are my area of interest and I work to study newer drugs in early phase of development and also its treatment using allogeneic stem cell transplantation. Patient appointments: 410-955-8893. Dr. Jain is rated as an Experienced provider by MediFind in the treatment of Blood Clots. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Splenomegaly, Bone Marrow Transplant, and Splenectomy. Dr. Jain is board certified in American Board Of Internal Medicine.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Experienced provider by MediFind in the treatment of Blood Clots. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Hemolytic Anemia, and Congenital Hemolytic Anemia. Dr. Naik is board certified in American Board Of Internal Medicine.

Dr. Ghiaur, a member of the Johns Hopkins Kimmel Cancer Center, is a physician-scientist whose primary interest is normal and malignant hematopoiesis, especially the role of the microenvironment in cell extrinsic drug resistance and persistence of minimal residual disease. He has distinguished himself as an outstanding laboratory-based investigator and a superior clinician. His research has translational potential in stem cell therapeutics, as well as acute leukemia and multiple myeloma. Dr. Ghiaur is rated as an Experienced provider by MediFind in the treatment of Blood Clots. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Ghiaur is board certified in American Board Of Internal Medicine.

Dr. Matthew Merguerian is a pediatric hematologist specializing in bleeding and clotting disorders. His research is focused on bleeding disorders resulting from platelet dysfunction. His lab is interested in understanding the mechanisms behind platelet dysfunction and in developing platelet-targeted therapies that could alleviate abnormal bleeding or clotting. Dr. Merguerian is rated as an Experienced provider by MediFind in the treatment of Blood Clots. His clinical expertise encompasses Blood Clots, Leukemia, and Immune Thrombocytopenic Purpura (ITP). Dr. Merguerian is board certified in American Board Of Pediatrics.

Kelly Norsworthy is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Norsworthy is rated as an Experienced provider by MediFind in the treatment of Blood Clots. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Leukemia, Bone Marrow Aspiration, and Splenectomy. Dr. Norsworthy is board certified in American Board Of Internal Medicine.

Dr. Ivana Gojo is a Hematologist/Oncologist in Baltimore. Her clinical focus is on diagnosis and management of patients with acute leukemias (AML, ALL) and other myeloid malignancies (MDS, MPNs, CML), with emphasis on the development of novel therapeutic approaches for these diseases. She is nationally and internationally recognized expert in clinical translation of novel therapeutics for acute leukemias and principal investigator on multiple multi-center investigator-initiated studies. Dr. Gojo joined the Johns Hopkins faculty in 2012 as the Co-Director of Leukemia Drug Development Program. She has served on the National Cancer Institute (NCI) Investigational Drug Steering Committee since 2014. Dr. Gojo received a Service Star Award from Johns Hopkins Medicine Service Excellence in 2018 for her exemplary care of leukemia patients. Dr. Gojo contributed to the clinical translational and drug development effort of multiple novel agents targeting pathogenic pathways in patients with acute leukemia. Her research efforts are now concentrated on the development and integration of novel immunotherapies into therapeutic armamentarium for patients with acute leukemia. She mentors basic and clinical research fellows and junior faculty on the development and design of novel clinical trials and mechanistic laboratory studies associated with these trials. She served as a leukemia team leader on the National Institute of Health (NIH)/NCI N01 grant (Phase II consortium) (2009-2011), and is co-principal investigator (PI) on the Experimental Therapeutics (ET)-Clinical Trial Network (CTN) UM1 grant supporting early clinical trials. Dr. Gojo has served on the National Comprehensive Cancer Network guideline panel for AML since 2019, Myeloid Growth Factor guideline panel since 2015 and previously served on the MPNs guideline panel (2016-2019). She has extensive experience in the regulatory aspects of drug development and served as the Chair (2015-2016) and Co-Chair (2014-2015) of the Cancer Research Review Committee at Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, and serves as a member of the SKCCC Biostatistics Core Advisory Committee and SKCCC Clinical Research Office Coordinating Center Oversight Committee. Dr. Gojo is rated as an Experienced provider by MediFind in the treatment of Blood Clots. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gojo is board certified in American Board Of Internal Medicine.

Richard Kolodrubetz is a primary care provider, practicing in Family Medicine in Ellicott City, Maryland. Dr. Kolodrubetz is rated as an Experienced provider by MediFind in the treatment of Blood Clots. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Sitosterolemia, Crohn's Disease, Irritable Bowel Syndrome (IBS), and High Cholesterol.

Uzochukwu Unegbu is a primary care provider, practicing in Family Medicine in Laurel, Maryland. Dr. Unegbu is rated as an Experienced provider by MediFind in the treatment of Blood Clots. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Michael Zang is a primary care provider, practicing in Internal Medicine in Catonsville, Maryland. Dr. Zang is rated as an Experienced provider by MediFind in the treatment of Blood Clots. His clinical expertise encompasses Pseudomyxoma Peritonei, Type 2 Diabetes (T2D), Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.